Costo-efficacia dell’amfotericina B liposomiale nella terapia dell’aspergillosi invasiva. Farmeconomia. Health Economics and Therapeutic Pathways, [S. l.], v. 5, n. 1, p. 47–61, 2004. DOI: 10.7175/fe.v5i1.786. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/786. Acesso em: 13 mar. 2026.